Medirom Healthcare Technologies (MRM) Financials

$1.00 +0.07 (+7.73%)

Closing price 03:56 PM Eastern

Extended Trading

$0.99 -0.01 (-1.20%)

As of 07:37 PM Eastern

Annual Income Statements for Medirom Healthcare Technologies

This table shows Medirom Healthcare Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	0.16	-5.22	-8.60	1.13	0.82	0.95
Consolidated Net Income / (Loss)	0.16	-5.22	-8.60	1.13	0.82	0.88
Net Income / (Loss) Continuing Operations	0.16	-5.22	-8.60	1.13	0.82	0.88
Total Pre-Tax Income	0.30	-6.07	-3.60	1.36	0.15	0.30
Total Operating Income	0.32	-7.23	-4.09	0.74	-2.78	-0.12
Total Gross Profit	8.75	4.15	12	14	11	14
Total Revenue	36	32	47	53	48	53
Operating Revenue	36	32	47	53	48	53
Total Cost of Revenue	27	28	35	38	37	38
Operating Cost of Revenue	27	28	35	38	37	38
Total Operating Expenses	8.44	11	16	14	14	14
Selling, General & Admin Expense	8.03	10	16	14	14	14
Impairment Charge	0.41	1.03	0.55	0.00	0.00	0.15
Total Other Income / (Expense), net	-0.01	1.16	0.49	0.63	2.93	0.42
Interest Expense	0.13	0.13	0.10	0.07	0.26	0.32
Interest & Investment Income	0.01	0.01	0.01	0.05	0.01	0.00
Other Income / (Expense), net	0.10	1.27	0.58	0.66	3.18	0.73
Income Tax Expense	0.15	-0.85	5.00	0.23	-0.67	-0.57
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	0.00	0.00	-0.00	-0.07
Basic Earnings per Share	$4.63	($133.97)	($1.76)	$0.23	$0.17	$0.19
Weighted Average Basic Shares Outstanding	3.75M	4.02M	4.88M	4.88M	4.88M	5.11M
Diluted Earnings per Share	$4.06	($133.97)	($1.76)	$0.21	$0.16	$0.18
Weighted Average Diluted Shares Outstanding	4.27M	4.02M	4.88M	5.47M	5.17M	5.85M
Weighted Average Basic & Diluted Shares Outstanding	-	4.82M	4.88M	4.88M	4.88M	7.90M

No quarterly income statements for Medirom Healthcare Technologies are available.

This table details how cash moves in and out of Medirom Healthcare Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	2.78	8.97	-9.28	1.78	-3.54	1.42
Net Cash From Operating Activities	0.07	-3.55	-4.84	-5.20	-4.48	-8.46
Net Cash From Continuing Operating Activities	0.07	-3.55	-4.84	-5.20	-4.48	-8.46
Net Income / (Loss) Continuing Operations	0.16	-5.22	-8.60	1.13	0.82	0.88
Consolidated Net Income / (Loss)	0.16	-5.22	-8.60	1.13	0.82	0.88
Depreciation Expense	0.43	0.60	1.10	1.40	1.79	1.84
Non-Cash Adjustments To Reconcile Net Income	-0.08	0.26	-1.70	-7.72	-9.68	-10
Changes in Operating Assets and Liabilities, net	-0.44	0.81	4.37	-0.01	2.59	-0.85
Net Cash From Investing Activities	-0.35	-1.35	-0.73	4.40	-2.33	2.30
Net Cash From Continuing Investing Activities	-0.35	-1.35	-0.73	4.40	-2.33	2.30
Purchase of Property, Plant & Equipment	-0.18	-1.01	-0.99	-1.26	-6.54	-3.59
Acquisitions	-0.03	-0.96	-3.26	-1.12	0.00	-0.14
Purchase of Investments	-0.47	-0.26	-0.69	0.00	-0.02	-0.04
Sale of Property, Plant & Equipment	0.05	0.03	0.00	0.31	0.00	0.00
Sale and/or Maturity of Investments	0.13	0.69	0.05	0.00	0.00	0.19
Other Investing Activities, net	0.15	0.15	4.15	6.48	4.23	5.87
Net Cash From Financing Activities	3.06	14	-3.72	2.58	3.27	7.58
Net Cash From Continuing Financing Activities	3.06	14	-3.72	2.58	3.27	7.58
Repayment of Debt	-2.23	-3.74	-2.18	-1.57	-0.70	-4.35
Issuance of Debt	0.00	7.51	0.00	4.15	2.84	6.42
Issuance of Preferred Equity	-	-	-	0.00	0.00	1.65
Issuance of Common Equity	6.44	11	0.76	0.00	1.14	3.86
Cash Interest Paid	0.11	0.10	0.09	0.06	0.25	0.30
Cash Income Taxes Paid	0.22	0.07	0.40	0.23	0.37	0.08

No quarterly cash flow statements for Medirom Healthcare Technologies are available.

This table presents Medirom Healthcare Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	44	55	50	51	49	51
Total Current Assets	13	20	12	18	12	17
Cash & Equivalents	4.73	14	3.22	4.59	0.75	2.09
Short-Term Investments	0.35	0.31	0.23	0.20	0.19	0.04
Note & Lease Receivable	3.94	3.98	4.71	5.99	4.30	4.11
Accounts Receivable	3.18	1.44	2.71	4.06	4.41	8.61
Inventories, net	0.05	0.08	0.16	0.87	0.99	0.96
Prepaid Expenses	0.44	0.46	0.97	2.22	1.83	1.38
Plant, Property, & Equipment, net	1.56	2.28	3.69	3.22	3.20	2.77
Total Noncurrent Assets	30	33	34	30	33	31
Long-Term Investments	0.13	0.00	0.46	0.40	0.58	0.56
Noncurrent Note & Lease Receivables	0.98	1.13	0.88	0.75	0.68	0.54
Goodwill	0.72	1.46	5.21	4.09	3.44	2.47
Intangible Assets	0.71	0.95	3.40	3.06	6.53	7.24
Noncurrent Deferred & Refundable Income Taxes	2.05	6.35	-	0.00	0.72	1.82
Other Noncurrent Operating Assets	25	23	24	22	21	19
Total Liabilities & Shareholders' Equity	44	55	50	51	49	51
Total Liabilities	38	51	52	52	47	44
Total Current Liabilities	21	26	28	28	25	27
Short-Term Debt	3.42	2.35	1.41	0.75	3.55	7.07
Accounts Payable	1.13	0.65	2.00	1.57	0.98	6.44
Accrued Expenses	4.12	8.61	7.52	10	8.95	2.07
Current Deferred & Payable Income Tax Liabilities	0.16	0.42	0.35	0.45	0.11	0.37
Other Current Liabilities	12	14	16	14	12	11
Total Noncurrent Liabilities	17	25	24	24	22	17
Long-Term Debt	1.39	6.47	6.48	8.72	7.46	4.86
Asset Retirement Reserve & Litigation Obligation	1.17	1.85	2.57	2.36	2.44	2.41
Other Noncurrent Operating Liabilities	11	17	15	13	12	10
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	0.00
Redeemable Noncontrolling Interest	-	0.00	-	-	0.00	1.27
Total Equity & Noncontrolling Interests	5.52	4.76	-1.81	-0.45	1.53	6.28
Total Preferred & Common Equity	5.52	4.76	-1.81	-0.45	1.50	5.93
Total Common Equity	5.52	4.76	-1.81	-0.45	1.50	5.93
Common Stock	12	21	22	19	0.95	4.49
Retained Earnings	-6.49	-16	-23	-19	0.57	1.46
Treasury Stock	-0.03	-0.03	-0.03	-0.02	-0.02	-0.02
Noncontrolling Interest	-	-	-	0.00	0.04	0.35

No quarterly balance sheets for Medirom Healthcare Technologies are available.

This table displays calculated financial ratios and metrics derived from Medirom Healthcare Technologies' official financial filings.

Metric	2019	2020	2021	2022	2023	2024
Period end date	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
DEI Shares Outstanding	0.00	4,822,500.00	4,882,500.00	4,882,500.00	4,882,500.00	7,901,950.00
DEI Adjusted Shares Outstanding	0.00	4,822,500.00	4,882,500.00	4,882,500.00	4,882,500.00	7,901,950.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	-1.08	-1.76	0.23	0.17	0.12
Growth Metrics	-	-	-	-	-	-
Revenue Growth	0.00%	-10.05%	45.15%	12.32%	-8.16%	8.84%
EBITDA Growth	0.00%	-737.56%	55.03%	215.89%	-21.37%	12.30%
EBIT Growth	0.00%	-1,537.56%	41.18%	139.75%	-71.26%	54.78%
NOPAT Growth	0.00%	-3,221.24%	43.45%	121.31%	-2,643.12%	97.85%
Net Income Growth	0.00%	-3,372.02%	-64.74%	113.14%	-27.76%	7.56%
EPS Growth	0.00%	-3,399.75%	98.68%	111.71%	-23.28%	14.32%
Operating Cash Flow Growth	0.00%	-4,998.01%	-36.34%	-7.52%	13.83%	-88.76%
Free Cash Flow Firm Growth	0.00%	0.00%	-458.90%	81.73%	-2,071.73%	73.11%
Invested Capital Growth	0.00%	-120.49%	416.83%	76.12%	187.84%	52.35%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-
Gross Margin	24.33%	12.84%	26.16%	27.36%	22.98%	27.07%
EBITDA Margin	2.33%	-16.53%	-5.12%	5.29%	4.53%	4.67%
Operating Margin	0.88%	-22.33%	-8.70%	1.39%	-5.73%	-0.22%
EBIT Margin	1.15%	-18.40%	-7.46%	2.64%	0.83%	1.17%
Profit (Net Income) Margin	0.44%	-16.14%	-18.31%	2.14%	1.69%	1.67%
Tax Burden Percent	52.95%	86.03%	239.03%	82.86%	557.90%	289.63%
Interest Burden Percent	72.77%	101.94%	102.75%	97.97%	36.58%	48.96%
Effective Tax Rate	48.76%	0.00%	0.00%	17.14%	-457.90%	-189.63%
Return on Invested Capital (ROIC)	4.84%	-379.95%	-384.55%	20.31%	-208.83%	-2.40%
ROIC Less NNEP Spread (ROIC-NNEP)	4.95%	-375.65%	401.44%	32.92%	28.28%	10.54%
Return on Net Nonoperating Assets (RNNOA)	-1.95%	278.38%	-198.92%	-120.35%	359.73%	21.73%
Return on Equity (ROE)	2.89%	-101.57%	-583.47%	-100.04%	150.90%	19.34%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	-263.15%	-34.82%	-305.69%	-43.88%
Operating Return on Assets (OROA)	0.95%	-12.01%	-6.65%	2.75%	0.80%	1.24%
Return on Assets (ROA)	0.36%	-10.54%	-16.34%	2.23%	1.64%	1.76%
Return on Common Equity (ROCE)	2.89%	-101.57%	-583.47%	-100.04%	145.88%	15.81%
Return on Equity Simple (ROE_SIMPLE)	2.89%	-109.75%	475.53%	-250.88%	54.56%	14.81%
Net Operating Profit after Tax (NOPAT)	0.16	-5.06	-2.86	0.61	-16	-0.33
NOPAT Margin	0.45%	-15.63%	-6.09%	1.16%	-32.00%	-0.63%
Net Nonoperating Expense Percent (NNEP)	-0.11%	-4.30%	-786.00%	-12.60%	-237.11%	-12.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	6.75%	-123.62%	-1.83%
Cost of Revenue to Revenue	75.67%	87.16%	73.84%	72.64%	77.02%	72.93%
SG&A Expenses to Revenue	22.31%	31.98%	33.69%	25.96%	28.71%	27.01%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	23.45%	35.16%	34.86%	25.96%	28.71%	27.28%
Earnings before Interest and Taxes (EBIT)	0.41	-5.95	-3.50	1.39	0.40	0.62
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.84	-5.35	-2.41	2.79	2.19	2.46
Valuation Ratios	-	-	-	-	-	-
Price to Book Value (P/BV)	2.17	2.42	0.00	0.00	18.66	0.85
Price to Tangible Book Value (P/TBV)	2.93	4.90	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.33	0.36	0.62	0.42	0.58	0.10
Price to Earnings (P/E)	75.19	0.00	0.00	19.48	34.10	5.32
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	1.33%	0.00%	0.00%	5.13%	2.93%	18.80%
Enterprise Value to Invested Capital (EV/IC)	3.46	0.00	15.26	6.87	3.40	0.95
Enterprise Value to Revenue (EV/Rev)	0.32	0.19	0.71	0.50	0.77	0.30
Enterprise Value to EBITDA (EV/EBITDA)	13.81	0.00	0.00	9.43	17.08	6.45
Enterprise Value to EBIT (EV/EBIT)	27.99	0.00	0.00	18.89	93.61	25.65
Enterprise Value to NOPAT (EV/NOPAT)	71.55	0.00	0.00	43.14	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	160.03	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-
Debt to Equity	0.87	1.85	-4.36	-21.03	7.18	1.58
Long-Term Debt to Equity	0.25	1.36	-3.58	-19.36	4.87	0.64
Financial Leverage	-0.39	-0.74	-0.50	-3.66	12.72	2.06
Leverage Ratio	7.93	9.64	35.71	-44.76	92.23	11.01
Compound Leverage Factor	5.77	9.83	36.69	-43.85	33.74	5.39
Debt to Total Capital	46.53%	64.96%	129.74%	104.99%	87.78%	61.23%
Short-Term Debt to Total Capital	33.11%	17.28%	23.16%	8.34%	28.32%	36.30%
Long-Term Debt to Total Capital	13.41%	47.68%	106.58%	96.66%	59.46%	24.94%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.29%	8.31%
Common Equity to Total Capital	53.47%	35.04%	-29.74%	-4.99%	11.93%	30.45%
Debt to EBITDA	5.73	-1.65	-3.28	3.40	5.02	4.84
Net Debt to EBITDA	-0.48	1.02	-1.66	1.53	4.33	3.75
Long-Term Debt to EBITDA	1.65	-1.21	-2.69	3.13	3.40	1.97
Debt to NOPAT	29.66	-1.74	-2.76	15.54	-0.71	-35.79
Net Debt to NOPAT	-2.50	1.08	-1.39	7.02	-0.61	-27.73
Long-Term Debt to NOPAT	8.55	-1.28	-2.27	14.31	-0.48	-14.58
Altman Z-Score	0.61	-0.17	0.01	0.62	1.08	0.96
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	3.33%	18.22%
Liquidity Ratios	-	-	-	-	-	-
Current Ratio	0.61	0.79	0.43	0.65	0.49	0.65
Quick Ratio	0.59	0.77	0.39	0.54	0.38	0.56
Cash Flow Metrics	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-1.02	-5.72	-1.04	-23	-6.10
Operating Cash Flow to CapEx	54.37%	-363.16%	-489.75%	-544.72%	-68.52%	-235.77%
Free Cash Flow to Firm to Interest Expense	0.00	-7.99	-55.13	-14.05	-86.74	-19.30
Operating Cash Flow to Interest Expense	0.58	-27.69	-46.63	-69.97	-17.14	-26.77
Operating Cash Flow Less CapEx to Interest Expense	-0.49	-35.31	-56.15	-82.81	-42.14	-38.12
Efficiency Ratios	-	-	-	-	-	-
Asset Turnover	0.82	0.65	0.89	1.04	0.97	1.05
Accounts Receivable Turnover	11.32	14.02	22.64	15.59	11.44	8.10
Inventory Turnover	536.66	441.49	289.69	74.55	40.15	39.31
Fixed Asset Turnover	23.13	16.85	15.72	15.27	15.09	17.66
Accounts Payable Turnover	24.13	31.74	26.14	21.41	29.25	10.36
Days Sales Outstanding (DSO)	32.25	26.04	16.12	23.41	31.90	45.08
Days Inventory Outstanding (DIO)	0.68	0.83	1.26	4.90	9.09	9.29
Days Payable Outstanding (DPO)	15.13	11.50	13.96	17.05	12.48	35.22
Cash Conversion Cycle (CCC)	17.80	15.37	3.42	11.26	28.51	19.15
Capital & Investment Metrics	-	-	-	-	-	-
Invested Capital	3.35	-0.69	2.17	3.83	11	17
Invested Capital Turnover	10.75	24.31	63.15	17.58	6.53	3.79
Increase / (Decrease) in Invested Capital	0.00	-4.03	2.86	1.65	7.19	5.77
Enterprise Value (EV)	12	6.08	33	26	37	16
Market Capitalization	12	12	29	22	28	5.03
Book Value per Share	$1.47	$1.18	($0.38)	($0.09)	$0.31	$1.21
Tangible Book Value per Share	$1.09	$0.58	($2.16)	($1.56)	($1.74)	($0.77)
Total Capital	10	14	6.08	9.02	13	19
Total Debt	4.81	8.82	7.89	9.48	11	12
Total Long-Term Debt	1.39	6.47	6.48	8.72	7.46	4.86
Net Debt	-0.41	-5.44	3.98	4.28	9.49	9.24
Capital Expenditures (CapEx)	0.13	0.98	0.99	0.96	6.54	3.59
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-9.80	-17	-18	-14	-10	-4.44
Debt-free Net Working Capital (DFNWC)	-4.72	-3.13	-14	-8.95	-9.24	-2.31
Net Working Capital (NWC)	-8.14	-5.48	-16	-9.70	-13	-9.38
Net Nonoperating Expense (NNE)	0.00	0.16	5.74	-0.52	-16	-1.21
Net Nonoperating Obligations (NNO)	-2.18	-5.44	3.98	4.28	9.49	9.24
Total Depreciation and Amortization (D&A)	0.43	0.60	1.10	1.40	1.79	1.84
Debt-free, Cash-free Net Working Capital to Revenue	-27.24%	-53.73%	-37.88%	-26.05%	-21.01%	-8.42%
Debt-free Net Working Capital to Revenue	-13.11%	-9.67%	-30.54%	-16.96%	-19.06%	-4.37%
Net Working Capital to Revenue	-22.62%	-16.92%	-33.53%	-18.39%	-26.39%	-17.78%
Earnings Adjustments	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($133.97)	($203.13)	$30.54	$0.17	$0.19
Adjusted Weighted Average Basic Shares Outstanding	0.00	4.02M	4.88M	4.88M	4.88M	5.11M
Adjusted Diluted Earnings per Share	$0.00	($133.97)	($203.13)	$27.23	$0.16	$0.18
Adjusted Weighted Average Diluted Shares Outstanding	0.00	4.02M	4.88M	5.47M	5.17M	5.85M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	4.82M	4.88M	4.88M	4.88M	7.90M
Normalized Net Operating Profit after Tax (NOPAT)	0.37	-4.34	-2.48	0.61	-1.95	0.02
Normalized NOPAT Margin	1.03%	-13.40%	-5.27%	1.16%	-4.01%	0.04%
Pre Tax Income Margin	0.84%	-18.75%	-7.66%	2.59%	0.30%	0.57%
Debt Service Ratios	-	-	-	-	-	-
EBIT to Interest Expense	3.31	-46.46	-33.75	18.72	1.53	1.96
NOPAT to Interest Expense	1.30	-39.46	-27.57	8.20	-59.25	-1.05
EBIT Less CapEx to Interest Expense	2.25	-54.08	-43.28	5.88	-23.48	-9.40
NOPAT Less CapEx to Interest Expense	0.23	-47.09	-37.09	-4.65	-84.26	-12.41
Payout Ratios	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	249.69%	-18.15%	-26.41%	0.00%	0.00%	0.00%

No quarterly metrics and ratios for Medirom Healthcare Technologies are available.

Financials Breakdown Chart

Medirom Healthcare Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Medirom Healthcare Technologies' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

Medirom Healthcare Technologies' net income appears to be on a downward trend, with a most recent value of $878.13 thousand in 2024, rising from $159.59 thousand in 2019. The previous period was $816.41 thousand in 2023. Check out Medirom Healthcare Technologies' forecast to explore projected trends and price targets.

Medirom Healthcare Technologies' total operating income in 2024 was -$115.03 thousand, based on the following breakdown:

Total Gross Profit: $14.27 million
Total Operating Expenses: $14.39 million

Over the last 5 years, Medirom Healthcare Technologies' total revenue changed from $35.98 million in 2019 to $52.74 million in 2024, a change of 46.6%.

Medirom Healthcare Technologies' total liabilities were at $43.86 million at the end of 2024, a 6.8% decrease from 2023, and a 14.6% increase since 2019.

In the past 5 years, Medirom Healthcare Technologies' cash and equivalents has ranged from $754.66 thousand in 2023 to $13.94 million in 2020, and is currently $2.09 million as of their latest financial filing in 2024.

Over the last 5 years, Medirom Healthcare Technologies' book value per share changed from 1.47 in 2019 to 1.21 in 2024, a change of -17.6%.

Related Companies

Financial statements for NASDAQ:MRM last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Medirom Healthcare Technologies (MRM) Financials

Financials Breakdown Chart

Medirom Healthcare Technologies Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Medirom Healthcare Technologies (MRM) Financials

Annual Income Statements for Medirom Healthcare Technologies

Quarterly Income Statements for Medirom Healthcare Technologies

Annual Cash Flow Statements for Medirom Healthcare Technologies

Quarterly Cash Flow Statements for Medirom Healthcare Technologies

Annual Balance Sheets for Medirom Healthcare Technologies

Quarterly Balance Sheets for Medirom Healthcare Technologies

Annual Metrics And Ratios for Medirom Healthcare Technologies

Quarterly Metrics And Ratios for Medirom Healthcare Technologies

Financials Breakdown Chart

Medirom Healthcare Technologies Financials - Frequently Asked Questions

When does Medirom Healthcare Technologies' financial year end?

How has Medirom Healthcare Technologies' net income changed over the last 5 years?

What is Medirom Healthcare Technologies' operating income?

How has Medirom Healthcare Technologies' revenue changed over the last 5 years?

How much debt does Medirom Healthcare Technologies have?

How much cash does Medirom Healthcare Technologies have?

How has Medirom Healthcare Technologies' book value per share changed over the last 5 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools